scholarly journals The relationship between chronic kidney disease and restless legs syndrome and its effective factors. A case-control study.

2021 ◽  
Vol 43 (5) ◽  
pp. 469-476
Author(s):  
Zahra Mousavi ◽  
Mehrdad Ghaemmaghami ◽  
Rasoul Alipour ◽  
Sona Rahimpour

I Restless legs syndrome (RLS), is a neurological disorder in which persons feel uncomfortable, especially at night, in the limbs and needs to move their legs. This condition worsens with rest. The aim of this study was to evaluate the frequency of restless legs syndrome in patients with renal insufficiency. In this case-control study, 180 patients with chronic kidney disease (90 hemodialysis patients and 90 non-dialysis patients) who referred to the nephrology clinic and dialysis ward of Imam Reza Hospital in Tabriz, were investigated. Data collection was done through a questionnaire form which was based on the criteria of the International Association for the Study of Restless Legs Syndrome. Among 180 patients in studied, 92 (51.7%) cases were male and 88 (48.3%) cases were female. The mean age of patients was 60.4 ± 17.2. So, 90 non-dialysis patients and 90 hemodialysis patients were evaluated. Of all the hemodialysis patients studied, 33 (37%) patients had restless legs syndrome, and among the non-dialysis patients, only 16 (18%) patients had restless legs syndrome. The frequency of restless legs syndrome is significantly higher in patients undergoing hemodialysis (P=0.001). There was also a meaningful difference about the frequency of restless legs syndrome among the male (77%) patients than females (23%) (P=0.001). A significant percentage (27%) of patients with renal failure suffer from restless legs syndrome and the hemodialysis patients are more involved in this disease, which needs more importance. Also, based on our findings in this study, men have a high probability of a conflict of restless legs syndrome than women

Author(s):  
T. Yusuf ◽  
Y. R. Raji ◽  
T. J. Lasisi ◽  
A. Daniel ◽  
O. T. Bamidele ◽  
...  

2014 ◽  
Vol 22 (3) ◽  
pp. 472-478 ◽  
Author(s):  
A. Romigi ◽  
M. Pierantozzi ◽  
F. Placidi ◽  
E. Evangelista ◽  
M. Albanese ◽  
...  

PLoS ONE ◽  
2015 ◽  
Vol 10 (4) ◽  
pp. e0122899 ◽  
Author(s):  
Ylenia Ingrasciotta ◽  
Janet Sultana ◽  
Francesco Giorgianni ◽  
Andrea Fontana ◽  
Antonio Santangelo ◽  
...  

2007 ◽  
Vol 230 (12) ◽  
pp. 1854-1859 ◽  
Author(s):  
Sheri J. Ross ◽  
Carl A. Osborne ◽  
Chalermpol Lekcharoensuk ◽  
Lori A. Koehler ◽  
David J. Polzin

2021 ◽  
Author(s):  
Qiao Wang ◽  
Jiahui Ma ◽  
Zhenxing Li ◽  
Zhi Li ◽  
Dong Huang ◽  
...  

Abstract Background: Chronic kidney disease (CKD) increases the susceptibility to the infection of herpes zoster (HZ). Less is known about the risk factors of HZ in CKD patients.Methods and Participants: This is a case-control study. CKD patients diagnosed with HZ infection between January 2015 and October 2020 in a tertiary hospital were identified. One age- and gender- matched control was paired for each case, matched to the date of initial HZ diagnose. The uni- and multivariate analysis were used to evaluate the risk factors for development of HZ in CKD patients.Results: Forty-six HZ patients and controls were identified. In general, about 80% (72 out of 92) patients were classified at end-stage renal disease (ESRD, CKD Ⅳ to Ⅴ). Multivariate analyses revealed that immunosuppressive agents (odds ratio: 12.50, 95% CI: 1.53-102.26, P=0.021) and dialysis (odds ratio: 3.33, 95% CI: 1.13-9.78, P=0.029) were independent risk factors of HZ in patient with CKD. Conclusion: Immunosuppressive medication and dialysis were associated with HZ infection in CKD. Further guideline may highlight the necessity of zoster vaccine for patients with CKD, who undertake immunosuppressive or dialysis treatment.


2021 ◽  
Vol Volume 13 ◽  
pp. 967-975
Author(s):  
Francesco Janes ◽  
Simone Lorenzut ◽  
Francesca Bevilacqua ◽  
Stefano de Biase ◽  
Michela Zilli ◽  
...  

2020 ◽  
Vol 15 (1) ◽  
pp. 9 ◽  
Author(s):  
AhmedS Bahammam ◽  
AljoharaS Almeneessie ◽  
Nada Alyousefi ◽  
Maha Alzahrani ◽  
Aisha Alsafi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document